Abbott tangles with Indian regulators over cough syrup complaint
Drugmaker Abbott Healthcare is challenging West Bengal's accusation that a sample of the company's cough syrup contained excessive levels of codeine, the second multinational to question India's regulatory testing regime in recent months.